نتائج البحث 551-560 من 5017 لعملية البحث عن ultra-short celiac disease
The PPCR will collect demographic and clinical data which many centers that deliver proton radiation therapy already collect in routine operations. Short Course ...
... small cell lung cancer and small cell lung cancer. Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib ...
Eligible patients with surgically accessible latent tumors desiring surgical resection will be enrolled to prospectively track short- and long-term outcomes.
... Small Lymphocytic Lymphoma (SLL). Rochester, Minn ... Small Lymphocytic Lymphoma (SLL). ... disease and factors that may determine disease progression and treatment ...
... and CNS metastases of non-small cell lung cancer (NSCLC). A Study to Evaluate Pluripotent Stem Cell Models for Spinal Muscular Atrophy (SMA) Patients.
The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these cystic kidney ...
Rochester, Minn., Jacksonville, Fla. Longitudinal Imaging Biomarkers of Disease Progression in Prodromal and Overt DLB. A Study of Lutetium Lu 177 Dotatate ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).
The purpose of this study is to evaluate the short-term outcomes and the quality of life (QOL) after cholecystectomy and hepatic artery infusion pump ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.